Jyothy Labs has cash to buy growth. Why it isn’t rushing

Friday, October 2, 2026 - 12:26
0 0
Jyothy Labs has cash to buy growth. Why it isn’t rushing
With ₹997 crore in cash and no debt, Jyothy Labs could use acquisitions to rebuild its portfolio after Henkel ended its Pril and Fa licensing deal. Instead, it is betting on new products and existing brands.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User